Interferon alfa 2b is an antiviral or antineoplastic drug, that was originally discovered in the laboratory of Charles Weissmann at the University of Zurich, developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers.

This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, mastocytosis and malignant melanoma...Wikipedia

Manufacturer's Website: Not Available                                                                                                             Average retail cost: $305/vial

Pegylated interferon alfa-2b, sold under the brand name is PegIntron among others, is a medication used to treat hepatitis C and melanoma. For hepatitis C it is typically used with ribavirin and cure rates are between 33 and 82%. For melanoma it is used in addition to surgery. It is given by injection under the skin...Wikipedia

Manufacturer's Website: PegIntron                                                                                                                      Average retail cost: $930/vial

Pegylated interferon alfa-2b, sold under the brand name is PegIntron among others, is a medication used to treat hepatitis C and melanoma. For hepatitis C it is typically used with ribavirin and cure rates are between 33 and 82%. For melanoma it is used in addition to surgery. It is given by injection under the skin...Wikipedia

Manufacturer's Website: Sylatron                                                                                                                          Average retail cost: $1,900/vial